Executive summary: The 2022 British Society for Rheumatology guideline for the treatment of psoriatic arthritis with biologic and targeted synthetic DMARDs
Autores principales: | , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Journal article |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|